Healthcare Equipment and Supplies
Company Overview of Xillix Ltd.
Xillix Ltd. develops and commercializes medical imaging technologies for detection and localization of cancer. The company develops fluorescence endoscopy systems, which allow physicians to see small, early stage cancer, and subtle pre-cancerous lesions. Its products include Xillix LIFE, Xillix LIFE-Lung, and Xillix LIFE-GI, which are fluorescence endoscopy systems for lung, gastro-intestinal track, and Ear, Nose & Throat (ENT). The company was founded in 2002 and is headquartered in Toronto, Canada. As of May 3, 2007, Xillix Ltd. operates as a subsidiary of Novadaq Technologies Inc.
620 University Avenue
Toronto, ON M5G2C1
Founded in 2002
Key Executives for Xillix Ltd.
Xillix Ltd. does not have any Key Executives recorded.
Similar Private Companies By Industry
|7D Surgical, Inc.||Americas|
|A.R. Medicom, Inc.||Americas|
|ABK Biomedical Inc.||Americas|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|NYC2012, Inc.||United States|
|Tax Management Inc||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Xillix Ltd., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.